StonvexLoading…
StonvexStonvexStonvexCore line items from USCB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $145.49M | $131.23M | $101.02M | $71.10M |
Operating Income | $35.92M | $32.48M | $21.80M | $27.09M |
Net Income | $26.10M | $24.67M | $16.55M | $20.14M |
EPS (Diluted) | $1.33 | $1.24 | Not available | Not available |
Total Assets | $2.79B | $2.58B | $2.34B | $2.09B |
Total Liabilities | $2.57B | $2.37B | $2.15B | $1.90B |
Cash & Equivalents | $38.48M | $77.03M | $41.06M | $54.17M |
Free Cash Flow OCF − CapEx | $42.50M | $34.52M | $22.38M | $28.86M |
Shares Outstanding | 19.65M | 19.83M | Not available | Not available |